Literature DB >> 7864162

Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney.

M Simon1, H J Gröne, O Jöhren, J Kullmer, K H Plate, W Risau, E Fuchs.   

Abstract

Vascular endothelial growth factor (VEGF) may modulate vascular permeability, chemotaxis for monocytes, and protease activity. In addition, VEGF may play a role in embryonic and tumor angiogenesis. In fetal mouse kidney, VEGF mRNA and protein expression have been demonstrated. This finding led to the hypothesis that VEGF might be involved in renal growth and development. To further elucidate the role of VEGF in human kidney, expression of VEGF and its receptors, the specific tyrosine kinase receptors, fit-1 and KDR, were studied. In fetal (6-24 gestational wk; mesonephros and metanephros) and adult kidney, VEGF mRNA and protein could be colocalized in glomerular epithelia and collecting duct cells by in situ hybridization and immunohistology. By reverse transcription-polymerase chain reaction, mRNA of three VEGF isoforms, VEGF121, VEGF165, and VEGF189, were found in fetal kidney and cortex, isolated glomeruli, and medulla of adult human kidney. KDR and flt-1 mRNA were coexpressed in endothelia of glomeruli and in peritubular capillaries in fetal and adult kidney. These data support the assumption that VEGF and its receptors may influence renal ontogenesis. We speculate that the constitutive expression of VEGF in adult kidney may be required for the function of VEGF receptor positive-fenestrated endothelia in glomeruli and postglomerular vessels. The expression of VEGF in collecting duct and of its receptors in medullary capillaries may in addition be relevant for maintaining medullary osmolality.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7864162     DOI: 10.1152/ajprenal.1995.268.2.F240

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  69 in total

Review 1.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

2.  Vascular endothelial growth factor receptor 2 direct interaction with nephrin links VEGF-A signals to actin in kidney podocytes.

Authors:  Claudia Bertuccio; Delma Veron; Pardeep K Aggarwal; Lawrence Holzman; Alda Tufro
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

3.  Mechanical stretch induces vascular permeability factor in human mesangial cells: mechanisms of signal transduction.

Authors:  G Gruden; S Thomas; D Burt; S Lane; G Chusney; S Sacks; G Viberti
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

4.  Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice.

Authors:  Dhanalakshmi Chinnasamy; Zhiya Yu; Marc R Theoret; Yangbing Zhao; Rajeev K Shrimali; Richard A Morgan; Steven A Feldman; Nicholas P Restifo; Steven A Rosenberg
Journal:  J Clin Invest       Date:  2010-10-11       Impact factor: 14.808

5.  TGF-β-activated kinase 1 is crucial in podocyte differentiation and glomerular capillary formation.

Authors:  Sung Il Kim; So-Young Lee; Zhibo Wang; Yan Ding; Nadeem Haque; Jiwang Zhang; Jing Zhou; Mary E Choi
Journal:  J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 10.121

6.  The transcription factor Net regulates the angiogenic switch.

Authors:  Hong Zheng; Christine Wasylyk; Abdelkader Ayadi; Joseph Abecassis; Jack A Schalken; Hermann Rogatsch; Nicolas Wernert; Sauveur-Michel Maira; Marie-Christine Multon; Bohdan Wasylyk
Journal:  Genes Dev       Date:  2003-09-15       Impact factor: 11.361

7.  Evaluation of novel antimouse VEGFR2 antibodies as potential antiangiogenic or vascular targeting agents for tumor therapy.

Authors:  Sophia Ran; Xianming Huang; Amber Downes; Philip E Thorpe
Journal:  Neoplasia       Date:  2003 Jul-Aug       Impact factor: 5.715

8.  The study on the relationship between serum vascular endothelial growth factor and proteinuria in adriamycin-induced nephrotic rats.

Authors:  Z Zhu; Y Wang; H Wang; A Deng
Journal:  J Tongji Med Univ       Date:  2001

Review 9.  New insights into molecular mechanisms of diabetic kidney disease.

Authors:  Shawn S Badal; Farhad R Danesh
Journal:  Am J Kidney Dis       Date:  2014-02       Impact factor: 8.860

10.  Amino acid transporter LAT3 is required for podocyte development and function.

Authors:  Yuji Sekine; Yukino Nishibori; Yoshihiro Akimoto; Akihiko Kudo; Noriko Ito; Daisuke Fukuhara; Ryota Kurayama; Eiji Higashihara; Ellappan Babu; Yoshikatsu Kanai; Katsuhiko Asanuma; Michio Nagata; Arindam Majumdar; Karl Tryggvason; Kunimasa Yan
Journal:  J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.